Skyrizi 600 mg Concentrate for solution for injection
- Licence status
- Active substances
- RISANKIZUMAB
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/19/1361/004
- Licence holder
- AbbVie Deutschland GmbH & Co. KG
Product documents
Licence information
- ATC code
- L04AC18 risankizumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 26/04/2019